Gilead Sciences, Inc. (NASDAQ:GILD) Receives $110.55 Average PT from Analysts
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-seven ratings firms that are covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have given a strong buy rating to […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-seven ratings firms that are covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have given a strong buy rating to […]
